Andere talen Arovella Therapeutics Limited

Aandelen

ALA

AU0000182784

Beurs gesloten - Australian S.E. Andere beurzen 08:10:04 13-09-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,1450 ^AUD	-3,33%		+3,57%	+26,09%

22/08	Arovella Therapeutics Limited rapporteert resultaten voor het volledige jaar dat eindigde op 30 juni 2024	CI
07/08	Arovella Therapeutics ontvangt positieve feedback van US FDA voor behandeling tegen bloedkanker; aandelen stijgen met 7%	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Arovella Therapeutics Limited Reports Earnings Results for the Full Year Ended June 30, 2024	22/08
Arovella Therapeutics Receives Positive Feedback From US FDA for Blood Cancer Treatment; Shares Jump 7%	07/08
Arovella Therapeutics Limited announced a financing transaction	04/07
Arovella Therapeutics, Teva Pharmaceuticals End ZolpiMist License Agreement	13/06
Arovella Therapeutics Completes Process Development for ALA-101 Manufacturing; Shares Jump 9%	05/06
Arovella Therapeutics Receives Firm Commitments for About AU$12.5 Million Raise	26/03
Arovella Therapeutics' ALA-101-onCARlytics Collaboration with Imugene Ends; Shares Down 12%	20/03
Arovella Therapeutics Limited Reports Earnings Results for the Half Year Ended December 31, 2023	28/02
Arovella Boosts Solid Tumor Pipeline with Novel CAR-iNKT Cell Armouring Tech License	30/01
Arovella Therapeutics Manufactures GMP-Grade Lentiviral Vector for Cancer Therapy Product; Shares Climb 4%	02/01
Arovella Therapeutics Ltd. Announces Change of Company Address	06/12
Arovella Therapeutics Appoints CFO	01/12
Arovella Therapeutics Limited Announces Changes to its Board	01/12
Arovella Therapeutics Limited Announces Executive Changes	01/12
Arovella Therapeutics Secures AU$2 Million Tax Rebate for Fiscal Year 2023	20/11
Australian Shares Flat With Positive Bias Amid Hopes of US Fed Keeping Rates Steady	12-10-23
Arovella Therapeutics Secures License for Tumor Targeting Antibody; Shares Fall 6%	12-10-23
Arovella Therapeutics Limited Announces Retirement of David Simmonds as Non-Executive Director	07-09-23
Arovella Therapeutics Limited Reports Earnings Results for the Full Year Ended June 30, 2023	31-08-23
Arovella Therapeutics Raises AU$2.2 Million From Oversubscribed Share Purchase Plan	11-07-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Arovella Therapeutics Limited

Aandelen

ALA

AU0000182784

Andere talen

Filters